ATE267581T1 - Orale arzneiformen mit schneller auflösbarkeit im mund und verfahren zu ihrer herstellung - Google Patents

Orale arzneiformen mit schneller auflösbarkeit im mund und verfahren zu ihrer herstellung

Info

Publication number
ATE267581T1
ATE267581T1 AT00964295T AT00964295T ATE267581T1 AT E267581 T1 ATE267581 T1 AT E267581T1 AT 00964295 T AT00964295 T AT 00964295T AT 00964295 T AT00964295 T AT 00964295T AT E267581 T1 ATE267581 T1 AT E267581T1
Authority
AT
Austria
Prior art keywords
mouth
production
rapid dissolution
mixture
dosage forms
Prior art date
Application number
AT00964295T
Other languages
English (en)
Inventor
Claude Laruelle
No L Zakarian
Rene Gimet
Dominique Toselli
Original Assignee
Cll Pharma Arenas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cll Pharma Arenas filed Critical Cll Pharma Arenas
Application granted granted Critical
Publication of ATE267581T1 publication Critical patent/ATE267581T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physiology (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Cardiology (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT00964295T 1999-09-15 2000-09-15 Orale arzneiformen mit schneller auflösbarkeit im mund und verfahren zu ihrer herstellung ATE267581T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9911513A FR2798289B1 (fr) 1999-09-15 1999-09-15 Formes galeniques a delitement rapide en bouche et leur procede de preparation
PCT/FR2000/002563 WO2001019336A1 (fr) 1999-09-15 2000-09-15 Formes galeniques a delitement rapide en bouche et leur procede de preparation

Publications (1)

Publication Number Publication Date
ATE267581T1 true ATE267581T1 (de) 2004-06-15

Family

ID=9549849

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00964295T ATE267581T1 (de) 1999-09-15 2000-09-15 Orale arzneiformen mit schneller auflösbarkeit im mund und verfahren zu ihrer herstellung

Country Status (18)

Country Link
US (1) US6669957B1 (de)
EP (1) EP1131050B8 (de)
JP (1) JP2003509353A (de)
KR (1) KR100854033B1 (de)
AT (1) ATE267581T1 (de)
AU (1) AU7526300A (de)
BR (1) BR0007151A (de)
CA (1) CA2350675A1 (de)
DE (1) DE60011036T2 (de)
ES (1) ES2222234T3 (de)
FR (1) FR2798289B1 (de)
HU (1) HUP0104914A3 (de)
MA (1) MA25323A1 (de)
MX (1) MX229299B (de)
PL (1) PL200672B1 (de)
PT (1) PT1131050E (de)
WO (1) WO2001019336A1 (de)
ZA (1) ZA200103280B (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020035107A1 (en) * 2000-06-20 2002-03-21 Stefan Henke Highly concentrated stable meloxicam solutions
DE10161077A1 (de) * 2001-12-12 2003-06-18 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen zur nadellosen Injektion
US8992980B2 (en) 2002-10-25 2015-03-31 Boehringer Ingelheim Vetmedica Gmbh Water-soluble meloxicam granules
GB0226076D0 (en) * 2002-11-08 2002-12-18 Rp Scherer Technologies Inc Improved formulations containing substituted imidazole derivatives
FI20022007A0 (fi) * 2002-11-08 2002-11-08 Juvantia Pharma Ltd Oy Oromukosaalinen valmiste ja menetelmä sen valmistamiseksi
EP1568369A1 (de) * 2004-02-23 2005-08-31 Boehringer Ingelheim Vetmedica Gmbh Verwendung von Meloxicam zur Behandlung von Atemwegserkrankungen bei Schweinen
GB2411355B (en) 2004-02-27 2006-02-22 Niche Generics Ltd Pharmaceutical composition
US20050220873A1 (en) * 2004-04-02 2005-10-06 Chien-Hsuan Han Pharmaceutical dosage forms having immediate and controlled release properties that contain a GABAB receptor agonist
US8007827B2 (en) * 2004-04-02 2011-08-30 Impax Laboratories, Inc. Pharmaceutical dosage forms having immediate release and/or controlled release properties
US20050220874A1 (en) * 2004-04-02 2005-10-06 Chien-Hsuan Han Pharmaceutical dosage forms having immediate release and controlled release properties that contain a GABAB receptor agonist
US20050226927A1 (en) * 2004-04-02 2005-10-13 Impax Laboratories, Inc. Pharmaceutical dosage forms having immediate release and/or controlled release properties that contain a GABAB receptor agonist
DE102004021281A1 (de) * 2004-04-29 2005-11-24 Boehringer Ingelheim Vetmedica Gmbh Verwendung von Meloxicam-Formulierungen in der Veterinärmedizin
TWI338583B (en) * 2004-05-20 2011-03-11 Otsuka Pharma Co Ltd Solid pharmaceutical formulation
JP5112619B2 (ja) * 2004-05-20 2013-01-09 大塚製薬株式会社 固形医薬製剤
DE102004030409A1 (de) * 2004-06-23 2006-01-26 Boehringer Ingelheim Vetmedica Gmbh Neue Verwendung von Meloxicam in der Veterinärmedizin
WO2006135491A2 (en) * 2005-06-08 2006-12-21 Basf Aktiengesellschaft Medicament carrier composition and method of forming a film therefrom
JP2009510007A (ja) * 2005-09-30 2009-03-12 ベーリンガー インゲルハイム フェトメディカ ゲゼルシャフト ミット ベシュレンクテル ハフツング メロキシカムを含む医薬調製
US7811604B1 (en) 2005-11-14 2010-10-12 Barr Laboratories, Inc. Non-effervescent, orally disintegrating solid pharmaceutical dosage forms comprising clozapine and methods of making and using the same
GB2443793B (en) * 2006-04-05 2010-12-01 Reckitt Benckiser Healthcare Product, method of manufacture and use
AU2008321418A1 (en) * 2007-11-14 2009-05-22 Jose Becera New extracts of deschampsia antarctica desv. with antineoplastic activity
KR101817361B1 (ko) * 2009-03-09 2018-01-11 에스피아이 파르마, 인크. 고도 압착성 및 내구성 직접 압축성 부형제 및 부형제 시스템
CN102647971B (zh) 2009-10-12 2016-03-16 贝林格尔.英格海姆维特梅迪卡有限公司 用于包含美洛昔康的组合物的容器
EP2314296A1 (de) * 2009-10-22 2011-04-27 Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi Im Mund zerfallende Betahistin Tabletten
SG183846A1 (en) 2010-03-03 2012-10-30 Boehringer Ingelheim Vetmed Use of meloxicam for the long-term treatment of musculoskeletal disorders in cats
US9795568B2 (en) 2010-05-05 2017-10-24 Boehringer Ingelheim Vetmedica Gmbh Low concentration meloxicam tablets
EP3069733B1 (de) * 2013-11-13 2022-08-10 National Defense Education and Research Foundation Neue acetaminophenverbindungszusammensetzung ohne nebenwirkungen für die leber
JP6858729B2 (ja) * 2018-05-25 2021-04-14 ▲財▼▲団▼法人国防教育研究基金会Ｎａｔｉｏｎａｌ Ｄｅｆｅｎｓｅ Ｅｄｕｃａｔｉｏｎ Ａｎｄ Ｒｅｓｅａｒｃｈ Ｆｏｕｎｄａｔｉｏｎ 肝臓に対する副作用がない、新しいアセトアミノフェン複合組成
FR3099881B1 (fr) 2019-08-13 2022-08-26 Ethypharm Sa Comprimé orodispersible d’opioide à faible dosage et son procédé de préparation.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH26730A (en) * 1988-12-30 1992-09-28 Ciba Geigy Ag Coated adhesive tablets
DE4200821A1 (de) * 1992-01-15 1993-07-22 Bayer Ag Geschmacksmaskierte pharmazeutische mittel
CA2245708C (en) * 1996-02-09 2008-01-22 Bruce Joseph Roser Solid formulations containing trehalose
AR017512A1 (es) * 1997-08-22 2001-09-12 Smithkline Beecham Corp Tabletas de metilcelulosa rapidamente desintegrables para administracion por via oral y procedimiento para prepararlas
US6465009B1 (en) * 1998-03-18 2002-10-15 Yamanouchi Pharmaceutical Co., Ltd. Water soluble polymer-based rapidly dissolving tablets and production processes thereof

Also Published As

Publication number Publication date
KR100854033B1 (ko) 2008-08-26
HUP0104914A2 (hu) 2002-07-29
AU7526300A (en) 2001-04-17
PL200672B1 (pl) 2009-01-30
US6669957B1 (en) 2003-12-30
FR2798289B1 (fr) 2004-12-31
CA2350675A1 (fr) 2001-03-22
ZA200103280B (en) 2001-10-25
HUP0104914A3 (en) 2003-05-28
MA25323A1 (fr) 2001-12-31
EP1131050A1 (de) 2001-09-12
DE60011036D1 (de) 2004-07-01
DE60011036T2 (de) 2005-06-23
WO2001019336A1 (fr) 2001-03-22
EP1131050B1 (de) 2004-05-26
ES2222234T3 (es) 2005-02-01
PL347693A1 (en) 2002-04-22
MX229299B (es) 2005-07-20
EP1131050B8 (de) 2004-11-10
BR0007151A (pt) 2001-08-14
KR20010089883A (ko) 2001-10-12
FR2798289A1 (fr) 2001-03-16
JP2003509353A (ja) 2003-03-11
PT1131050E (pt) 2004-11-30

Similar Documents

Publication Publication Date Title
ATE267581T1 (de) Orale arzneiformen mit schneller auflösbarkeit im mund und verfahren zu ihrer herstellung
US4695591A (en) Controlled release dosage forms comprising hydroxypropylmethylcellulose
WO1999059544A3 (en) Orally disintegrable tablets
EP1275381A4 (de) Feste überzogene zubereitungen mit zeitabhängiger freisetzung zur oralen verabreichung
MX9804008A (es) Formulaciones farmaceuticas.
WO2004002447A3 (en) Dosage forms for increasing the solubility and extending the release of drugs such as e.g. topiramate and phenyton
JPH04501425A (ja) ロラタジン、イブプロフェンおよびプソイドエフェドリンを含む薬剤組成物
WO2001041770A3 (en) Nanoparticulate eplerenone compositions
EP1243267A3 (de) Amoxycillin und Clavulanat enthaltende pharmazeutische Zusammensetzung
ATE312595T1 (de) Formulierung mit mehrfach gepulster wirkstofffreisetzung
HUP0300530A2 (hu) Hidrofil/lipofil polimer mátrix adagolási kiszerelés
CA2417686A1 (en) Manufacture of oral dosage forms delivering both immediate release and sustained release drugs
US20070122475A1 (en) Taste masking composition
CA2352211A1 (en) Sustained release matrix systems for highly soluble drugs
JPH08208520A (ja) 経口薬剤構成物
MY136136A (en) Pharmaceutical compositions containing terbinafin and use thereof
WO2002024203A3 (en) Controlled release formulations for oral administration
CA2383212A1 (en) Controlled release oral dosage suitable for oral administration
AP2001002084A0 (en) Orally administered controlled delivery system for once daily adminstration of ciprofloxacin
CA2356306A1 (en) Sulfated phosphatidylinositols, their preparation and use
AU758880B2 (en) Timed release tablet comprising naproxen and pseudoephedrine
US6129931A (en) Controlled-release, drug-delivery tableted composition including a complex between poly(maleic diacid-alkyl vinyl ether) and polyvinylpyrrolidone
ATE212840T1 (de) Oral anzuwendende feste arzneizubereitungen mit modulierter wirkstoffabgabe enthaltend nicorandil und verfahren zu deren herstellung
MY145885A (en) Controlled release formulations for oral administration

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1131050

Country of ref document: EP

REN Ceased due to non-payment of the annual fee